# US 2025/0082572 A1 · Topical formulations for handling atopic dermatitis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082572 A1
- Document ID: US20250082572A1
- Status: Published application
- Kind: A1
- Application number: 18/723,046
- Filed: 2022-12-22
- Published: 2025-03-13
- Earliest claimed: 2021-12-26
- Assignees: Gold Feet Ltd
- Applicants: Gold Feet Ltd
- Inventors: Arie WALDMAN
- Web page: https://patentgrep.com/patent/US20250082572A1

## CPC

- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/06: Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61P 17/00: Drugs for dermatological disorders
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A topical composition for use in treating dermatitis, comprising from 0.5 to 5 wt % olive oil, from 0.3 to 3 wt % date honey, from 0.3 to 3 wt % coconut oil, and a steroid anti-inflammatory agent in an amount of from 0.5 ppm to 50 ppm, homogeneously admixed in a pharmaceutically acceptable cream. A method of making the composition is also disclosed.

## Claims

### Claim 1

A topical composition for use in treating dermatitis, comprising from 0.5 to 5 wt % olive oil, from 0.3 to 3 wt % date honey, from 0.3 to 3 wt % coconut oil, and a steroid anti-inflammatory agent in an amount of from 0.5 ppm to 50 ppm, homogeneously admixed in a pharmaceutically acceptable cream.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said steroid is selected from the group consisting of hydrocortisone, fluocinolone acetonide, alclometasone dipropionate, desonide, hydrocortisone butyrate, fluticasone propionate, betamethasone valerate, betamethasone dipropionate, betamethasone valerate, fluticasone propionate, fluocinonide, desoximetasone, betamethasone dipropionate, halobetasol propionate, and clobetasol propionate.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said dermatitis is atopic dermatitis.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said cream is an oil in water emulsion comprising paraffin.

### Claim 5 (depends on 4)

The composition of claim 4, wherein oil in water emulsion comprising paraffin is aquosum cream.

### Claim 6 (depends on 1)

The composition of claim 1 for use in treating atopic dermatitis, comprising from 1 to 20 ppm clobetasol propionate.

### Claim 7 (depends on 1)

The composition of claim 1 for use in treating atopic dermatitis, comprising from 5 to 15 ppm clobetasol propionate.

### Claim 8 (depends on 1)

The composition of claim 1, further comprising pharmaceutically acceptable carriers, excipients, or diluents.

### Claim 9 (depends on 1)

The composition of claim 1, further comprising an additional active agent selected from antiviral, antibacterial, antifungal, antibiotic, antiseptic, antihistamine, analgesic, anti-inflammatory, immunomodulatory, or a material adjusting biological tissue permeability.

### Claim 10 (depends on 1)

A process for manufacturing the composition of claim 1, comprising homogenizing from 0.5 to 5 wt % olive oil, from 0.3 to 3 wt % date honey, from 0.3 to 3 wt % coconut oil, a steroid anti-inflammatory agent in an amount of from 0.5 ppm to 50 ppm, optionally additives and additional active agents, in an oil-in-water emulsion comprising paraffin, at a temperature from ambient to 100° C.
